HWM
IBRX icon

Hemington Wealth Management’s ImmunityBio IBRX Stock Holding History

Hemington Wealth Management’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$0 Buy
12
+3
+33% +$8 ﹤0.01% 1623
2025
Q2 		$0 Sell
9
-75
-89% -$202 ﹤0.01% 1603
2025
Q1 		$0 Sell
84
-76
-48% -$230 ﹤0.01% 1614
2024
Q4 		$0 Buy
160
+118
+281% +$492 ﹤0.01% 1652
2024
Q3 		$0 Buy
+42
New +$194 ﹤0.01% 1603

Other funds holding IBRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $5.44B AUM 26.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Hemington Wealth Management's IBRX Position: Q3 2025 in Review

Hemington Wealth Management increased its ImmunityBio (IBRX) stake by 33% in Q3 2025, buying an estimated $8 and bringing the position to 12 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1623.

Hemington Wealth Management first reported a position in IBRX in Q3 2024 and has held it in 5 quarters since. 264 funds tracked by Wall St. Rank hold IBRX as of Q3 2025.

  • Hemington Wealth Management held 12 shares of ImmunityBio worth $0 as of Q3 2025.
  • Hemington Wealth Management bought 3 ImmunityBio shares in Q3 2025, an estimated $8.
  • ImmunityBio made up ﹤0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #1623 holding.
  • Hemington Wealth Management first reported a position in ImmunityBio in Q3 2024 and has held it in 5 quarters since.
  • 264 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.